semaglutide tracker app Journey Shotsy | GLP-1 Tracker for

for these drugs in 2023 (the latest year I found data for) was $71,700,000,000 (yes, 71.7 billion

tirzepatide, you will see they are similar in some ways, but they work a bit differently and have slightly different benefits

Gastroparesis slows stomach emptying, raising concerns about GLP-1 medications like Ozempic

Join our physician-supervised program for personalized support.

As semaglutide patents expire, and global manufacturing scales, a new phase of access is beginning

Injectable weight-loss medications, known as GLP-1s, can be an important tool for losing weightand reducing the risk of a host of health problems.